Microneedles as a potential tool for live cell delivery in retinal diseases: a case study of Top2b-edited RPCs with matched biomaterials

Ke Yu; Siyuan Peng; Xin Pan; Zhengwei Huang; Wenhao Wang

doi:10.37349/ebmx.2025.101354

Exploration of Biomat-X ›› 2025, Vol. 2 ›› Issue (1) :101354 DOI: 10.37349/ebmx.2025.101354

Commentary

research-article

Microneedles as a potential tool for live cell delivery in retinal diseases: a case study of Top2b-edited RPCs with matched biomaterials

Ke Yu ¹^,^†
, Siyuan Peng ¹^,^†
, Xin Pan ¹
, Zhengwei Huang ²^,^*
, Wenhao Wang ¹^,^*

Author information +

History +

PDF (509KB)

Abstract

Keywords

Top2b editing / retinal cell / electroporation / microneedles

Cite this article

Download citation ▾

Ke Yu, Siyuan Peng, Xin Pan, Zhengwei Huang, Wenhao Wang. Microneedles as a potential tool for live cell delivery in retinal diseases: a case study of Top2b-edited RPCs with matched biomaterials. Exploration of Biomat-X, 2025, 2 (1) : 101354 DOI:10.37349/ebmx.2025.101354

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Wu KY, Dhaliwal JK, Sasitharan A, Kalevar A. Cell Therapy for Retinal Degenerative Diseases: Progress and Prospects. Pharmaceutics. 2024; 16: 1299.

[2]	Van Gelder RN, Chiang MF, Dyer MA, Greenwell TN, Levin LA, Wong RO, et al. Regenerative and restorative medicine for eye disease. Nat Med. 2022; 28: 1149-56.

[3]	Lyu YL, Lin C, Azarova AM, Cai L, Wang JC, Liu LF. Role of topoisomerase IIbeta in the expression of developmentally regulated genes. Mol Cell Biol. 2006; 26: 7929-41.

[4]	Dabrowski AC, Logan AR, Rayaji R, Rodriguez B, Cai L, Vazquez M. Top2b regulates morphological and migratory properties of retinal progenitor cells in vivo and upon transplantable matrix substrates. Explor Biomat X. 2025; 2: 101335.

[5]	Akhter MH, Ahmad I, Alshahrani MY, Al-Harbi AI, Khalilullah H, Afzal O, et al. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels. 2022; 8: 82.

[6]	Tawfik M, Chen F, Goldberg JL, Sabel BA. Nanomedicine and drug delivery to the retina: current status and implications for gene therapy. Naunyn Schmiedebergs Arch Pharmacol. 2022; 395: 1477-507.

[7]	Liu J, Hu J, Li Y, Hu N, Wang Y, Chang B, et al. Microneedle-mediated biomimetic nanoparticles for targeted antioxidant and anti-inflammatory therapy in age-related macular degeneration. J Control Release. 2025; 384: 113908.

[8]	Faizi HS, Nasiri MI, Wu Y, Mishra D, Donnelly RF, Minhas MU, et al. Deferasirox nanosuspension loaded dissolving microneedles for ocular drug delivery. Int J Pharm. 2024; 664: 124614.

[9]	Gote V, Sikder S, Sicotte J, Pal D. Ocular Drug Delivery: Present Innovations and Future Challenges. J Pharmacol Exp Ther. 2019; 370: 602-24.

[10]	Mbituyimana B, Adhikari M, Qi F, Shi Z, Fu L, Yang G. Microneedle-based cell delivery and cell sampling for biomedical applications. J Control Release. 2023; 362: 692-714.